Polymerix Corporation, a specialty pharmaceutical company, develops therapeutic products based on therapeutic polymer technology. The company’s nonsteroidal anti-inflammatory drugs, PolyNSAIDs, are non-inflammatory, biodegradable medical device coatings. The company’s drugs, PolyNSAIDs, bioerode to generate potent non-steroidal anti-inflammatory and antiseptic effects. Its PolyNSAIDs are being developed as coatings for implanted medical devices, such as orthopedic implants, sutures, surgical meshes, coronary stents, and vascular grafts, as well as long-acting formulations for drug delivery. NSAIDs address each element of the body's response to injury inflammation, pain and a cascade of events that leads to tissue remodeling. The company’s PolymerDrug platform offers the potential for controlled dosing and longer delivery intervals for drugs. Polymerix Corporation was founded in 2000 and is based in Piscataway, New Jersey.